🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers have designed a study medicine called MK-5684 as a new way to t...
Status
Completed
Location
Celerion ( Site 0001)
Start Date
2024-07-11
Trial ID
NCT06554639
Treatments Being Tested
This is a phase 3, randomized, open-label study of opevesostat compared to ...
Status
Recruiting
Location
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040)
Start Date
2023-12-31
Trial ID
NCT06136624
Researchers have designed a study medicine called opevesostat as a new way ...
Status
Completed
Location
Celerion ( Site 0001)
Start Date
2024-12-18
Trial ID
NCT06633419
Treatments Being Tested
The primary objectives of this study are to evaluate the safety and tolerab...
Status
Completed
Location
Peking University First Hospital-Urology ( Site 0001)
Start Date
2024-01-30
Trial ID
NCT06136598
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of opevesost...
Status
Completed
Location
National Cancer Center Hospital East ( Site 0001)
Start Date
2023-11-14
Trial ID
NCT06104449
Treatments Being Tested
The purpose of this substudy is to assess the efficacy and safety of ifinat...
Status
Recruiting
Location
UCLA Hematology & Oncology ( Site 0003)
Start Date
2025-07-03
Trial ID
NCT06863272
Treatments Being Tested
Researchers have designed a study medicine called opevesostat as a new way ...
Status
Completed
Location
Clinical Pharmacology of Miami ( Site 0002)
Start Date
2025-05-13
Trial ID
NCT06860243
Treatments Being Tested
This is a study of opevesostat in healthy adult male participants. The purp...
Status
Completed
Location
Quotient Sciences ( Site 0001)
Start Date
2024-09-19
Trial ID
NCT06566989
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of opevesost...
Status
Recruiting
Location
The University of Arizona Cancer Center - North Campus ( Site 0073)
Start Date
2023-12-18
Trial ID
NCT06136650
Researchers have designed a study medicine called opevesostat as a new way ...
Status
Completed
Location
Celerion, Inc. ( Site 0001)
Start Date
2026-05-11
Trial ID
NCT07548606
Treatments Being Tested